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Objectives: The aim of this study was to characterize a collection of 520 Salmonella
enterica serovar Infantis strains isolated from food (poultry meat), human infections and
environmental sources from the years 2010, 2013 and 2015 in Switzerland.
Methods: We performed antimicrobial susceptibility testing and pulsed-field gel
electrophoresis (PFGE) analysis on all 520 S. Infantis isolates, and whole genome
sequencing (WGS) on 32 selected isolates.
Results: The majority (74.8%) of the isolates was multidrug resistant (MDR). PFGE
analysis revealed that 270 (51.9%) isolates shared an identity of 90%. All isolates
subjected to WGS belonged to sequence type (ST) 32 or a double-locus variant thereof
(one isolate). Seven (21.9%) of the sequenced isolates were phylogenetically related to
the broiler-associated clone B that emerged in Hungary and subsequently spread within
and outside of Europe. In addition, three isolates harboring blaCTX−M−65 on a predicted
large (∼320 kb) plasmid grouped in a distinct cluster.
Conclusion: This study documents the presence of the Hungarian clone B and related
clones in food and human isolates between 2010 and 2015, and the emergence of a
blaCTX−M−65 harboring MDR S. serovar Infantis lineage.
Keywords: Salmonella Infantis, Hungarian clone B, blaCTX−M−65, food, humans
INTRODUCTION
Non-typhoidal Salmonella enterica (NTS) are one of the most important etiological agents
of foodborne diarrheal diseases in humans worldwide and cause an estimated 80.3 million
foodborne illnesses a year (Majowicz et al., 2010). Although most cases of salmonellosis are
self-limiting episodes of gastro-enteritis, severe cases of infection, including bacteremia and
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meningitis require antimicrobial treatment. Ciprofloxacin is a
common first-line antimicrobial for treating salmonellosis but
because fluoroquinolones are not used for treating children,
β-lactams (ampicillin or third-generation cephalosporins)
are of equal importance (Medalla et al., 2016). Multidrug-
resistant (MDR) NTS is associated with higher morbidity and
mortality outcomes compared to drug-susceptible strains and
is a major public health concern (Mølbak, 2005). Salmonella
enterica subsp. enterica serovar Infantis (S. serovar Infantis)
has emerged as the fourth most common serovar causing
human salmonellosis in Europe, with 1,846 cases reported
by the EU/EEA countries in 2014 (European Food Safety
Authority [EFSA] and European Centre for Disease Prevention
[ECDC], 2016). Poultry, especially from layer and broiler
farms, as well as pigs are the main animal reservoirs for
S. serovar Infantis (Nógrády et al., 2012). This serovar is
also dominant in broiler meat, accounting for 35.9% of all
Salmonella isolates reported from EU countries in 2014
(European Food Safety Authority [EFSA] and European
Centre for Disease Prevention [ECDC], 2016). Over the
last few years, antimicrobial resistance has emerged in S.
serovar Infantis isolates from human and animal sources in
various European countries and consequently, this serovar,
together with S. Kentucky, contributes significantly to the
numbers of MDR Salmonella in Europe (Nógrády et al.,
2008; Dionisi et al., 2011). Closely related MDR clones
of S. serovar Infantis have disseminated among broiler
populations and associated animal growing environments,
ultimately being disseminated into the food chain and then
into humans in European countries such as Hungary, Poland
and Austria (Nógrády et al., 2012). Isolates belonging to these
clones are characterized by their resistance to nalidixic acid,
sulfamethoxazole, streptomycin and tetracycline (NaSSuT).
Recently, resistance to third generation cephalosporins has
emerged in S. serovar Infantis isolates in Italy, due to the
circulation of an extended-spectrum β-lactamase (ESBL)
producing, MDR clone with additional reduced susceptibility
to ciprofloxacin (Franco et al., 2015). The spread of MDR
S. serovar Infantis clones throughout the food production
system (mainly poultry and poultry meat) and in humans is
highly worrisome and warrants improved understanding of its
epidemiology. In Switzerland, S. serovar Infantis ranks among
the top five of Salmonella serovars registered by the National
Centre for Enteropathogenic Bacteria and Listeria (NENT).
However, currently no data on antimicrobial resistance patterns
or clonal relationships of the isolates exist, despite its clinical
importance.
The aim of this study was to characterize a collection
of 520 S. serovar Infantis strains isolated from food
(poultry meat), human infections and environmental
sources from the years 2010, 2013 and 2015 in Switzerland
(i) by determining their phenotypic antibiotic resistance
profiles using the disk diffusion method and (ii) by
assessing genotypic characteristics and clonal relatedness
using molecular methods including pulsed-field gel
electrophoresis (PFGE), PCR, and whole genome sequencing
(WGS).
MATERIALS AND METHODS
Bacterial Strains
A total of 520 non-duplicate S. serovar Infantis isolates from
human infections (n = 84), poultry meat (n = 418) and
other sources (n = 18) were collected during 2010, 2013 and
2015 at the National Centre for Enteropathogenic Bacteria and
Listeria (NENT), Switzerland. The isolates had been forwarded
by hospitals, diagnostic laboratories or surveillance programs
of retail markets and food or feed producing facilities for final
species-level identification according to the White-Kauffmann-
Le Minor scheme (Grimont and Weill, 2008).
Antimicrobial Susceptibility Testing
Antimicrobial susceptibility testing was performed using the
disk-diffusion method and the antibiotics ampicillin (AM),
amoxicillin-clavulanic acid (AMC), cefotaxime (CTX), nalidixic
acid (Na), ciprofloxacin (CIP), gentamicin (GM), kanamycin
(K), streptomycin (S), sulfamethoxazole (Su), trimethoprim
(TMP), tetracycline (T), and chloramphenicol (C) (Becton
Dickinson, Heidelberg, Germany). Results were interpreted
according to Clinical and Laboratory Standards Institute (CLSI)
performance standards (CLSI, 2016). For sulfamethoxazole, for
which breakpoints are not listed separately from trimethoprim,
an inhibition zone of ≤10 mm was interpreted as resistant.
Isolates displaying resistance to three or more classes of
antimicrobials (counting β-lactams as one class) were defined
as multidrug-resistant (MDR). Synergistic effects between AMC
and CTX were regarded as an indication of the presence of an
ESBL producer (Kaur et al., 2013).
Detection and Characterization of
Extended-Spectrum β-Lactamase (bla)
Genes
Putative ESBL producers were grown on BrillianceTMESBL agar
(Oxoid, Hampshire, United Kingdom). The presence of blaESBLs
was confirmed by PCR by screening for blaTEM, blaSHV, and
blaCTX−M alleles belonging to CTX-M groups 1, 2, 8, 9, and
25 as described previously (Woodford et al., 2006; Geser et al.,
2012; Zurfluh et al., 2015). Synthesis of primers and DNA
custom sequencing was carried out by Microsynth (Balgach,
Switzerland) and nucleotide sequences were analyzed with CLC
Main Workbench 6.6.1. For database searches the BLASTN
program of NCBI1 was used.
Pulsed-Field Gel Electrophoresis
Pulsed-field gel electrophoresis was performed according to
the PulseNet protocol of the Centers for Disease Control and
Prevention (CDC)2, using the restriction enzyme XbaI (Roche,
Mannheim, Germany) and Salmonella serovar Braenderup strain
H9812 (ATCC BAA 664) as the reference strain. Restricted
DNA was separated in a 1% agarose gel (BioRad, Cressier,
Switzerland) at 12◦C for 20 h at 6 V/cm under linear ramp
1http://www.ncbi.nlm.nih.gov/blast/
2http://www.cdc.gov/pulsenet/protocols.htm
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TABLE 1 | S. Infantis strains used for genome comparison in this study.
Strain Alias Year of isolation Region of isolation Sample type Source GenBank accession no. Reference
SI3337/12 3337 12 H 2012 Hungary Animal Broiler MIJS00000000 Wilk et al., 2016
SI757/13 757 13 H 2013 Hungary Animal Broiler MIJT00000000 Wilk et al., 2016
SI786/13 786 13H 2013 Hungary Animal Broiler MIJR00000000 Wilk et al., 2016
SI1070/16 1070 16 2016 Hungary Animal Broiler MRUX00000000 Wilk et al., 2017
13017779/5 brochM113 2013 Italy Animal Broiler ERR1014114 Franco et al., 2015
12037823/11 brchM112 2012 Italy Animal Broiler ERR1014117 Franco et al., 2015
13002124/1 huM12013 2013 Italy Clinical Human ERR1014112 Franco et al., 2015
14026835 italy 2014 2014 Italy Clinical Human ERR1014119 Franco et al., 2015
CFSAN042077 CFSAN042077 2015 United States Food Broiler FSIS1502916 Tate et al., 2017
120100 120100 2008 Israel Food Unknown SAMN04217889 Aviv et al., 2016
119944 119944 2008 Israel Clinical Human ASRF01000000 Aviv et al., 2014
07041415 broMESC07 2007 Italy Food Broiler ERR1014109 Franco et al., 2015
09051564/79 broMESC09 2009 Italy Animal Broiler ERR1014118 Franco et al., 2015
FDA00001200 CFSAN014765 2008 Israel Food Basil SRR3453168 CFSANa
06029746 bromIEs6 2006 Italy Food Broiler ERR1014111 Franco et al., 2015
335 3 335 3 israel 1970 Israel Clinical Human SAMN02470973 Aviv et al., 2016
09051564/33 guifoIEc9 2009 Italy Animal Guinea fowl ERR1014110 Franco et al., 2015
1326/28 infan649235 1973 United Kingdom Animal Broiler SAMEA3106395 Olasz et al., 2015
aU.S. Food and Drug Administration’s Center for Food Safety and Applied Nutrition.
with switch times from 2 to 64 s and 120◦ included angle using
a CHEF-DR III system (BIO-RAD, Munich, Germany). Gels
were stained with ethidium bromide and visualized under UV
light with Gel Doc (BIO-RAD, Munich, Germany). GelCompar
II software (Applied Maths NV, Sint-Martens-Latem, Belgium)
was used for analysis. Pairwise similarities between the XbaI
PFGE patterns were calculated by the DICE similarity coefficient.
Clustering was based on the unweighted pair-group method
with averages, setting tolerance at 1% and optimization at
0.5%.
Whole Genome Sequencing
Whole genome sequencing was performed with a representative
subset of 32 isolates selected with regard to their PFGE pattern,
source, year of isolation or presence of blaCTX−M−65. DNA
extraction was performed with the Wizard R© Genomic DNA
Purification Kit according to the manufacturers protocol
(Promega AG, Dübendorf, Switzerland). Sequencing was
performed on a MiSeq sequencer (Illumina, San Diego, CA,
United States), utilizing a 600 cycle Nextera XT library kit.
Trimmed Fastq data sets were de novo assembled using the
TABLE 2 | Origin and antimicrobial resistance characteristics among S. Infantis in Switzerland.
No. isolates with
No. isolates analyzed resistance pattern resistance to
Year/Source NaSSuTa NaSuTb AMPc CIPd
2010 191
Food 167 64 (38.3%) 72 (43.1%) 4 (2.4%) 3 (1.8%)
Human 19 2 (10.5%) 5 (26.3%) 0 (0%) 0 (0%)
Other 5 2 (40%) 0 (0%) 0 (0%) 0 (0%)
2013 161
Food 131 64 (48.9%) 32 (24.4%) 3 (2.3%) 7 (5.3%)
Human 27 8 (29.6%) 8 (29.6%) 3 (11.1%) 1 (3.7%)
Other 3 0 (0%) 0 (0%) 0 (0%) 0 (0%)
2015 168
Food 120 31 (25.8%) 57 (47.5%) 6 (5%) 13 (10.8%)
Human 38 14 (36.8%) 12 (31.6%) 4 (10.5%) 0 (0%)
Other 10 4 (10%) 4 (10%) 0 (0%) 0 (0%)
aNaSSuT, nalidixic acid-streptomycin-sulfamethoxazole-tetracycline resistance pattern. bNaSuT, nalidixic acid-sulfamethoxazole-tetracycline resistance pattern. cAMP,
ampicillin. dCIP, ciprofloxacin.
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recommended workflow on CLC Genomics Work bench
version 8.0 (CLC bio, Aarhus, Denmark). Genomic contigs
were annotated using the RAST annotation server (Aziz
et al., 2008). The assembled sequences were uploaded to the
http://www.genomicepidemiology.org/ server. Sequences of the
seven housekeeping genes (aroC, dnaN, hemD, hisD, purE, sucA
and thrA) were analyzed to identify multilocus sequence types
(MLST)3, antibiotic resistance genes4, and plasmid replicon
types5, using each website’s algorithms and databases. Routine
processing of genome datasets was carried out by in-house perl
scripts (available upon request). A local customized database
of Salmonella chromosomal and plasmid genomes from NCBI
was created and used for annotation, plasmid analysis, and
homology detection with BLAST suite (Altschul et al., 1990).
Phylogenetic analysis was conducted using a multiloci analysis
based on a published core gene dataset (Leekitcharoenphon
et al., 2012). Alleles in 2780 core gene loci across all the genomes
were identified with Salmonella enterica subsp. enterica serovar
Typhimurium LT2 genome as the reference. Of these loci,
1,500 core gene loci were randomly chosen and alleles were
concatenated. The data matrix of alleles was subject to multiple
alignment and phylogenetic analysis using tools available in
MEGA7 suite (Kumar et al., 2016). The phylogenetic tree was
built using the Neighbor-Joining algorithm in the MEGA 7 suite
with 9,562 positions across 50 genomes for the final analysis.
For genome comparison, whole genome draft sequences of
Salmonella enterica serovar Infantis strains from public databases
were retrieved, including four recent strains of the prevalent
Hungarian clone B of S. serovar Infantis from Hungary (Wilk
et al., 2016, 2017), five blaESBL harboring, and eight non-blaESBL
harboring strains from Italy, Israel and the United States. (Aviv
et al., 2014; Franco et al., 2015), and one fully susceptible strain
from the United Kingdom (Olasz et al., 2015). An overview of the
strains and their GenBank accession numbers is given in Table 1.
For plasmid comparison, annotations were obtained from RAST
(Aziz et al., 2008), and compared with pCSAM042077 (Tate et al.,
2017) on the SEED server for additional verification (Overbeek
et al., 2013).
RESULTS
Antimicrobial Susceptibility Testing
The distribution of resistance phenotypes among the S. serovar
Infantis isolates is summarized in the Table 2 and shown in detail
in technical Supplementary Tables S1–S3.
Multidrug resistant was detected in 389 (74.8%) of the isolates.
Thereof, the majority (379/520, 72.9% of all isolates) showed a
combined resistance pattern to nalidixic acid, sulfamethoxazole
and tetracycline, with (NaSSuT) or without streptomycin
(NaSuT). The NaSSut pattern was detected in 189 (36.3% of all
isolates) and the NaSuT pattern in 190 (36.5% of all isolates).
Resistance to ampicillin and ciprofloxacin was verified in 20
3https://cge.cbs.dtu.dk/services/MLST/
4https://cge.cbs.dtu.dk/services/ResFinder/
5https://cge.cbs.dtu.dk/services/PlasmidFinder/
FIGURE 1 | Percentage of S. serovar Infantis isolates with the nalidixic
acid-sulfamethoxazole-tetracycline (NaSuT), or the nalidixic
acid-streptomycin-sulfamethoxazole-tetracycline resistance pattern (NaSSuT)
resistance pattern and resistance to ampicillin and ciprofloxacin in 2010, 2013
and 2015.
(3.8%) and 24 (4.6%) of the isolates, respectively, and showed a
rising prevalence between 2010 and 2015 for both antimicrobials,
as illustrated in Figure 1. A total of 496 (95.4% of all isolates)
tested within the intermediate range for ciprofloxacin, according
to CLSI breakpoints. An ESBL phenotype and growth on
BrillianceTMESBL agar was recorded for three strains (0.6% of
all isolates), whereof two originated from humans (isolates 21-13
and 125-15) and one (isolate 144-13) from food (Table 3 and
Supplementary Tables S2, S3).
WGS
The genomic characteristics of the 32 genomes are listed in
Supplementary Tables S1–S3. The average genome size, %G+C,
and number of coding DNA sequences (CDS) of the isolates was
4.88 mbp (range:4.56–4.98 mbp), 52.2% (range: 52.1–52.3%), and
4812 CDS (range: 4443–4912 CDS), respectively.
Detection of Resistance Genes by PCR
and by WGS
All three isolates displaying an ESBL phenotype showed the
presence of the blaCTX−M−65 gene by PCR. WGS analysis
using ResFinder confirmed the presence of the blaCTX−M−65
genes. All blaCTX−M−65-positive isolates carried other resistance
genes aph4-la, aadA1 and aac3-IVa (aminoglycoside resistance),
fosA (fosfomycin resistance), floR (phenicol resistance), sul1
(sulphonamide resistance), tetA (tetracycline resistance), and
dfrA14 (trimethoprim resistance) (Table 3 and Supplementary
Tables S2, S3), while strains 21-13 and 144-13 also carried
the aph3′-lc gene (aminoglycoside resistance). WGS of 23
MDR, non-ESBL producing isolates revealed the presence of
aadA1, sul1, and tetA resistance genes throughout. Food isolate
115-10 additionally carried the non-ESBL blaTEM−116 gene. The
environmental isolate 70-15 from Israel additionally harbored
floR and dfrA14 and MDR strain 119-15 isolated from animal
feed also carried aph3′-lc and dfrA14 (Table 3 and Supplementary
Table S3).
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TABLE 3 | Characteristics of 32 sequenced S. Infantis from food, diseased humans and other sources from 2010, 2013 and 2015 from Switzerland.
Strain ID Year of isolation Source Phenotypic
resistance patterna
Resistance genes
detected by WGS
ST PFGE cluster Accession no.
17-10 2010 Food NaSSuT aadA1, sul1, tetA 32 – NAPL00000000
78-10 2010 Human NaSSuT aadA1, sul1, tetA 32 C NKQL00000000
79-10 2010 Human NaSSuT aadA1, sul1, tetA 32 A NAPI00000000
111-10 2010 Other Su none 32 – NAPF00000000
115-10 2010 Food NaSuT aadA1, sul1, tetA,
blaTEM−116
32 – NAPD00000000
169-10 2010 Food NaSuT aadA1, sul1, tetA 32 B NAOU00000000
186-10 2010 Human NaSuT aadA1, sul1, tetA 32 D NAOS00000000
193-10 2010 Food NaSSuT aadA1, sul1, tetA 32 – NAOR00000000
21-13 2013 Human NaSSuT, AMP, CTX aph4-la, aadA1,
aac3-IVa, aph3′-lc,
blaCTX−M−65, fosA,
floR, sul1, tetA, dfrA14
32 variantb – NAPP00000000
25-13 2013 Food NaSSuT aadA1, sul1, tetA 32 D NAPO00000000
31-13 2013 Food NaSSuT aadA1, sul1, tetA 32 – NAPN00000000
53-13 2013 Human NaSuT aadA1, sul1, tetA 32 E NAPV00000000
61-13 2013 Food Su none 32 – NAPJ00000000
100-13 2013 Food none none 32 – NAPU00000000
112-13 2013 Food NaSuT aadA1, sul1, tetA 32 – NAPE00000000
123-13 2013 Food NaSuT aadA1, sul1, tetA 32 C NAPB00000000
133-13 2013 Food NaSuT aadA1, sul1, tetA 32 – NAOY00000000
144-13 2013 Food NaSSuT, AMP, CTX aph4-la, aadA1,
aac3-IVa, aph3′-lc,
blaCTX−M−65, fosA,
floR, sul1, tetA, dfrA14
32 – NAOX00000000
153-13 2013 Human Na, Su aadA1, sul1 32 – NAOV00000000
173-13 2013 Human NaSSuT aadA1, sul1, tetA 32 C NBAS00000000
3-15 2015 Human NaSSuT aadA1, sul1, tetA 32 B NAPW00000000
15-15 2015 Human NaSSuT aadA1, sul1, tetA 32 A NAPM00000000
20-15 2015 Human NaSuT aadA1, sul1, tetA 32 – NAPK00000000
69-15 2015 Human NaSuT aadA1, sul1, tetA 32 – NAPH00000000
70-15 2015 Other NaSuT aadA1, sul1, tetA, floR,
dfrA14
32 – NKQM00000000
97-15 2015 Human NaSSuT aadA1, sul1, tetA 32 – NAPG00000000
99-15 2015 Human None None 32 – NJAM00000000
119-15 2015 Other NaSSuT aadA1, aph3’-lc, sul1,
tetA, dfrA14
32 – NAPC00000000
125-15 2015 Human NaSuT, AMP, CTX aph4-la, aadA1,
aac3-IVa, blaCTX−M−65,
fosA, floR, sul1, tetA,
dfrA14
32 – NAPA00000000
126-15 2015 Human None None 32 – NAOZ00000000
149-15 2015 Food NaSuT aadA1, sul1, tetA 32 – NAOW00000000
169-15 2015 Food NaSSuT aadA1, sul1, tetA 32 C NAOT00000000
aNaSSuT, nalidixic acid-streptomycin-sulfamethoxazole- tetracycline resistance pattern; NaSuT, nalidixic acid-sulfamethoxazole-tetracycline resistance pattern; bdouble-
locus variant (purE 288 and sucA 565) of ST32. AMP, ampicillin; CTX, cefotaxime; Na, nalidixic acid; PFGE, pulsed-field gel electrophoresis; Su, sulfamethoxazole;
ST, sequence type; WGS, whole genome sequencing; –, isolate not belonging to any specific PFGE cluster. Resistance genes: aadA1, aph3′-lc, aac3-IVa, aph4-la,
aminoglycoside; bla, β-lactam; fosA, fosfomycin; floR, phenicol; sul1, sulphonamide; tetA, tetracycline; dfrA14, trimethoprim.
Whole genome sequencing did not detect any resistance
genes in six non-MDR isolates (Table 3 and Supplementary
Tables S1–S3), except for human isolate 153-13 which showed
intermediate resistance to streptomycin and harbored aadA1 and
sul1 (Table 3 and Supplementary Table S2).
Detection of Plasmids and Replicon
Types among the Isolates
By mapping WGS assemblies to the 320 kb plasmid
pCFSAN42077 from blaCTX−M−65 carrying food isolate
CFSAN42077 (Tate et al., 2017), contigs or regions similar to
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FIGURE 2 | Multiple sequence alignment with pCSAM042077 from S. Infantis from food from the United States (FSIS150291), of a blaCTX−M−65 cassette on putative
∼320 kb plasmids from three S. Infantis strains from food (144-13) and diseased humans (21-13 and 125-15) from Switzerland and one S. Infantis strain from Italy
(ERR1014119). The ∼5 kb cassette consists of blaCTX−M−65 followed by an IS5/IS1182 family transposase and a gene encoding a TonB-dependent siderophore
receptor, and one or two hypothetical genes. The cassette is flanked on either side by the IS6 transposase. The fipA gene is of varied lengths, or absent.
this plasmid in isolates 21-13, 144-13 and 125-15 were detected
(data not shown). Specific contigs bearing the blaCTX−M−65 gene
and surrounding loci were identified (Figure 2). The ∼5 kb
cassette consisted of blaCTX−M−65 followed by an IS5/IS1182
family transposase and a gene encoding a TonB-dependent
siderophore receptor. The 5′-end is flanked by an IS6 family
transposase upstream of the fipA gene, which is truncated in
pCFSAN42077. By comparison, fipA is absent in p14026835, a
blaCTX−M−65 harboring plasmid from human S. Infantis isolate
14026835 from Italy (ERR1014119), as shown in Figure 2. As
predicted, no replicons were detected in the genomes of these
three blaCTX−M−65 harboring isolates (Franco et al., 2015).
For other isolates in this study, WGS analysis showed the
presence of incompatibility group IncFII (p96A) plasmid
(accession #JQ418521), in the fully susceptible human
isolate 99-15 (N15-1280), Incl1 (accession #AP005147)
in fully susceptible food isolate 100-13 (N13-1368), and
pESA2 and IncFII (pCTU2) (accession nos. #CP000784 and
#FN543095, respectively) in fully susceptible human isolate
126-15 (N15-1729) (data not shown).
PFGE Cluster Analysis, MLST and
Phylogenetic Analysis
PFGE
Pulsed-field gel electrophoresis analysis revealed 190 distinct
XbaI restriction patterns (all patterns are available upon request).
Of the 520 isolates, 270 (51.9%) shared a similarity of 90%.
Five clusters A–E showing a similarity of >93% and consisting
of 121 (23.3% of total) isolates were detected. Isolates within a
cluster had indistinguishable profiles. The clusters A–E contained
21 (4% of the total), 18 (3.5%), 27 (5.2%), 43 (8.3%) and 12
(2.3%) isolates, respectively. Isolates from sources other than
human infections or food (e.g., environmental samples) were not
detected within these clusters.
MLST and Phylogenetic Analysis
All 32 isolates subjected to WGS belonged to sequence type (ST)
ST32, except isolate 21-13, which was a double-locus variant
(purE and sucA) of ST32 (Table 3).
Genetic relatedness was investigated by mapping the 32
genomes to the genome sequences of isolates belonging to the
Hungarian clone B from broilers, the blaESBL, and non-blaESBL
harboring strains from Italy, Israel and United States. The
resulting unrooted phylogenetic tree is shown in Figure 3. The
isolates segregated into eight major clusters. Clusters determined
by PFGE and by WGS did not correlate.
Close phylogenetic relatedness with strains 3337 12 H, 757 13
H, 786 13H, 1070 16 belonging to the Hungarian clone B was
detected in seven (21.9%) of the sequenced strains and included
human and food isolates from 2010, 2013 and 2015 (Figure 3).
The blaCTX−M−65 harboring isolates 21-13, 144-13 and 125-15
were more distantly related to the isolates that clustered with the
Hungarian clone B. All three isolates were closely related to, and
formed a distinct cluster with the blaCTX−M−65 harboring human
isolate (italy 2014) from Italy and the food isolate CFSAN 042077
from the United States.
Four (12.5%) of the genomes (isolates 15-15, 169-10, 112-13
and 133-13, respectively) grouped in a distinct cluster with
non-blaESBL, pESI-like harboring strains isolated previously from
broiler meat in Italy. One environmental isolate (isolate 70-15)
originating from Israel formed a cluster with three strains from
Israel (pESI containing 120100 and 119944, and CFSAN014765).
Two fully susceptible isolates (63-13 and 126-15) were placed
in the phylogenetic tree together with the non-pESI containing
strain 335 3 isolated in Israel in 1971 (Figure 3).
Accession Numbers
The accession numbers of the 32 sequenced isolates are listed in
Table 3 and Supplementary Tables S1–S3. This Whole Genome
Shotgun project has been deposited at DDBJ/ENA/GenBank
under the accession NAOX00000000. The version described in
this paper is version NAOX00000000.1.
DISCUSSION
S. serovar Infantis has emerged as an important disseminator
of MDR in the food chain, representing a threat to human
health (Nógrády et al., 2012). The majority of strains in this
study exhibited either the NaSuT pattern or the characteristic
NaSSuT pattern previously identified in the MDR S. Infantis
clone B that emerged in broilers in farms in Hungary and
subsequently spread within and outside of Europe, including
to the countries of Poland, Austria, Germany, Israel and Japan
(Hauser et al., 2012; Nógrády et al., 2012). WGS performed
in this study detected clonality in strains deemed different by
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FIGURE 3 | Core gene analysis based phylogeny of 32 selected S. serovar
Infantis from food, diseased humans and environmental sources from 2010,
2013 and 2015 from Switzerland and of S. serovar Infantis from Hungary,
Israel, Italy and United States. Alleles from 1500 randomly chosen core genes
from more than 2770 conserved loci were used to build a phylogenetic tree.
The data matrix of alleles was subject to multiple alignments. The
phylogenetic tree was built using the Neighbor-Joining algorithm in the MEGA
7 suite with 9,562 positions across 50 genomes for the final analysis. Bar
indicates 20 single nucleotide polymorphisms (SNP). Blue box: Isolates
belonging to the Hungarian clone. Red box: Isolates harboring blaCTX−M−65.
PFGE and provides evidence that the Hungarian clone B has
persisted since at least 2010 in Switzerland within the food
chain and is associated with human disease. Strains belonging
to three other closely related clusters were less prevalent but
showed similar resistance patterns and persistence within food
and human isolates.
In addition, we observed the occurrence of S. serovar
Infantis harboring blaCTX−M−65. This bla gene has been detected
previously in one human S. serovar Infantis isolate in Great
Britain and in one from Italy (Burke et al., 2014), and
furthermore, in an outbreak of S. Infantis in Ecuador (Cartelle
Gestal et al., 2016), as well as in food in the United States.
The results presented in this study show that the blaCTX−M−65
harboring S. serovar Infantis from Switzerland belong to a unique
lineage but are similar to the strains from Italy and the United
States, suggesting the emergence of a blaCTX−M−65 harboring,
MDR S. serovar Infantis lineage in Europe as well as in North
and South America. Moreover, this study shows that this lineage
has been present in food and humans at least as early as 2013 in
Europe.
Whole genome sequencing of these strains indicate the
presence of a ∼320 kb plasmid similar to the pESI plasmid,
a megaplasmid carrying multiple resistance and virulence
genes originally detected in S. serovar Infantis in Israel
in 2008 (Aviv et al., 2014). In addition, resistance genes
drfA14 and fosA (trimethoprim and phenicol resistance genes,
respectively) which are also found on pESI-like plasmids (Franco
et al., 2015), were detected in all blaCTX−M−65 harboring
strains. Several other non-blaESBL harboring strains from this
study had a close phylogenetic-relatedness to strains from
Israel and Italy which harbor non-blaESBL pESI or pESI-
like plasmids (Aviv et al., 2014), suggesting that certain S.
serovar Infantis clones or lineages are acquiring these plasmids
independently.
Our results correlate with the recent detection of a clone
harboring a pESI-like plasmid and the blaCTX−M−1 gene in the
broiler industry and humans in Italy (Franco et al., 2015), and
suggest that some S. serovar Infantis clones harboring pESI-
like plasmids may be undergoing a microevolution by acquiring
blaESBL genes. While in Europe blaCTX−M−1 is prevalent
within the poultry industry and has been well documented
(Zurfluh et al., 2014), blaCTX−M−65 has rarely been described.
By contrast, it is a prevalent blaESBL gene in animal and
human E. coli strains and S. serovar Indiana isolates in China
(Bai et al., 2016), from where it may have disseminated via
horizontal transfer. However, further studies are needed to
clarify the origins of this blaESBL gene and to characterize
and compare the plasmids carrying blaESBL genes in S. serovar
Infantis.
The emergence of MDR S. Infantis with resistance to third
generation cephalosporins in food and in humans is of great
concern, particularly since these strains show intermediate
resistance to ciprofloxacin. The use of fluoroquinolones for
the treatment of infections caused by such strains may
be associated with unfavorable treatment outcomes and the
selection of high-level ciprofloxacin resistance (Humphries et al.,
2012).
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This study extends our knowledge on clones of S. serovar
Infantis circulating in food and causing disease in humans
and provides evidence for the emergence of an MDR,
ESBL-producing clone harboring blaCTX−M−65 in Switzerland.
Our results highlight the necessity of strategies to reduce the
prevalence of S. serovar Infantis within the food producing
industry.
AUTHOR CONTRIBUTIONS
DH, BT, and RS designed the study. KZ, DH, and DA carried
out the microbiological and molecular biological tests. GG, HC,
FN, and BT carried out whole genome sequencing. MN-I, RS,
DH, GG, and BT analyzed and interpreted the data. MN-I
drafted the manuscript. All authors read and approved the final
manuscript.
ACKNOWLEDGMENT
This work was partly supported by the Swiss Federal Office of
Public Health, Division Communicable Disease.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: http://journal.frontiersin.org/article/10.3389/fmicb.
2017.01322/full#supplementary-material
REFERENCES
Altschul, S. F., Gish, W., Miller, W., Myers, E. W., and Lipman, D. J. (1990). Basic
local alignment search tool. J. Mol. Biol. 215, 403–410. doi: 10.1016/S0022-
2836(05)80360-2
Aviv, G., Rahav, G., and Gal-Mor, O. (2016). Horizontal Transfer of the Salmonella
enterica serovar Infantis resistance and virulence plasmid pESI to the gut
microbiota of warm-blooded hosts. mBio 7:e1395-16. doi: 10.1128/mBio.
01395-16
Aviv, G., Tsyba, K., Steck, N., Salmon-Divon, M., Cornelius, A., Rahav, G., et al.
(2014). A unique megaplasmid contributes to stress tolerance and pathogenicity
of an emergent Salmonella enterica serovar infantis strain. Environ. Microbiol.
16, 977–994. doi: 10.1111/1462-2920.12351
Aziz, R. K., Bartels, D., Best, A. A., DeJongh, M., Disz, T., Edwards, R. A., et al.
(2008). The RAST Server: rapid annotations using subsystems technology. BMC
Genomics 9:75. doi: 10.1186/1471-2164-9-75
Bai, L., Zhao, J., Gan, X., Gan, X., Wang, J., Zhang, X., et al. (2016). Emergence
and diversity of Salmonella enterica serovar Indiana isolates with concurrent
resistance to ciprofloxacin and cefotaxime from patients and food-producing
animals in China. Antimicrob. Agents Chemother. 60, 3365–3371. doi: 10.1128/
AAC.02849-15
Burke, L., Hopkins, K. L., Meunier, D., de Pinna, E., Fitzgerald-Hughes, D.,
Humphreys, H., et al. (2014). Resistance to third-generation cephalosporins in
human non-typhoidal Salmonella enterica isolates from England and Wales,
2010-12. J. Antimicrob. Chemother. 69, 977–981. doi: 10.1093/jac/dkt469
Cartelle Gestal, M., Zurita, J., Paz, Y., Mino, A., Ortega-Paredes, D., and Alcocer, I.
(2016). Characterization of a small outbreak of Salmonella enterica serovar
Infantis that harbour CTX-M-65 in Ecuador. Braz. J. Infect. Dis. 20, 406–407.
doi: 10.1016/j.bjid.2016.03.007
CLSI. (2016). Performance Standards for Antimicrobial Susceptibility Testing;
Twenty-sixth Informational Supplement M100S. Wayne, PA: Clinical and
Laboratory Standards Institute.
Dionisi, A. M., Lucarelli, C., Benedetti, I., Owczarek, S., and Luzzi, I. (2011).
Molecular characterisation of multidrug-resistant Salmonella enterica serotype
Infantis from humans, animals and the environment in Italy. Int. J. Antimicrob.
Agents 38, 384–389. doi: 10.1016/j.ijantimicag.2011.07.001
European Food Safety Authority [EFSA] and European Centre for Disease
Prevention [ECDC]. (2016). The European Union summary report on
antimicrobial resistance in zoonotic and indicator bacteria from humans,
animals and food in 2014. EFSA J. 14, 4380. doi: 10.2903/j.efsa.2016.4380
Franco, A., Leekitcharoenphon, P., Feltrin, F., Alba, P., Cordaro, G., Iurescia, M.,
et al. (2015). Emergence of a clonal lineage of multidrug-resistant ESBL-
producing Salmonella infantis transmitted from broilers and broiler meat to
humans in Italy between 2011 and 2014. PLoS ONE 10:e0144802. doi: 10.1371/
journal.pone.0144802
Geser, N., Stephan, R., Korczak, B. M., Beutin, L., and Hächler, H. (2012).
Molecular identification of extended-spectrum-β-lactamase genes from
Enterobacteriaceae isolated from healthy human carriers in Switzerland.
Antimicrob. Agents Chemother. 56, 1609–1612. doi: 10.1128/AAC.
05539-11
Grimont, P. A. D., and Weill, F. X. (2008). Antigenic Formulae of the Salmonella
Serovars. Paris: Institut Pasteur.
Hauser, E., Tietze, E., Helmuth, R., Junker, E., Prager, R., Schroeter, A., et al. (2012).
Clonal dissemination of Salmonella enterica serovar Infantis in Germany.
Foodborne Pathog. Dis. 9, 352–360. doi: 10.1089/fpd.2011.1038
Humphries, R. M., Fang, F. C., Aarestrup, F. M., and Hindler, J. A. (2012). In
vitro susceptibility testing of fluoroquinolone activity against Salmonella: recent
changes to CLSI standards. Clin. Infect. Dis. 55, 1107–1113. doi: 10.1093/cid/
cis600
Kaur, J., Chopra, S., Sheevani, and Mahajan, G. (2013). Modified double disc
synergy test to detect ESBL production in urinary isolates of Escherichia coli
and Klebsiella pneumoniae. J. Clin. Diagn. Res. 7, 229–233. doi: 10.7860/JCDR/
2013/4619.2734
Kumar, S. G., Stecher, G., and Tamura, K. (2016). MEGA7: Molecular evolutionary
genetics analysis version 7.0 for bigger datasets. Mol. Biol. Evol. 33, 1870–1874.
doi: 10.1093/molbev/msw054
Leekitcharoenphon, P., Lukjancenko, O., Friis, C., Aarestrup, F. M., and
Ussery, D. W. (2012). Genomic variation in Salmonella enterica core genes
for epidemiological typing. BMC Genomics 13:88. doi: 10.1186/1471-2164-
13-88
Majowicz, S. E., Musto, J., Scallan, E., Angulo, F. J., Kirk, M., O’Brien, S. J., et al.
(2010). The global burden of nontyphoidal Salmonella gastroenteritis. Clin.
Infect. Dis. 50, 882–889. doi: 10.1086/650733
Medalla, F., Gu, W., Mahon, B. E., Judd, M., Folster, J., Griffin, P. M., et al. (2016).
Estimated incidence of antimicrobial drug-resistant nontyphoidal Salmonella
infections, United States, 2004-2012. Emerg. Infect. Dis. 23, 29–37. doi: 10.3201/
eid2301.160771
Mølbak, K. (2005). Human health consequences of antimicrobial drug-resistant
Salmonella and other foodborne pathogens. Clin. Infect. Dis. 41, 1613–1620.
doi: 10.1086/497599
Nógrády, N., Kardos, G., Bistyák, A., Turcsányi, I., Mészáros, J., Galántai, Z.,
et al. (2008). Prevalence and characterization of Salmonella infantis isolates
originating from different points of the broiler chicken-human food chain in
Hungary. Int. J. Food Microbiol. 127, 162–167. doi: 10.1016/j.ijfoodmicro.2008.
07.005
Nógrády, N., Király, M., Davies, R., and Nagy, B. (2012). Multidrug resistant clones
of Salmonella infantis of broiler origin in Europe. Int. J. Food Microbiol. 157,
108–112. doi: 10.1016/j.ijfoodmicro.2012.04.007
Olasz, F., Nagy, T., Szabó, M., Kiss, J., Szmolka, A., Barta, E., et al. (2015). Genome
sequences of three Salmonella enterica subsp. enterica serovar infantis strains
from healthy broiler chicks in Hungary and in the United Kingdom. Genome
Announc. 3:e1468-14. doi: 10.1128/genomeA.01468-14
Overbeek, R., Olson, R., Pusch, G. D., Olsen, G. J., Davis, J. J., Disz, T.,
et al. (2013). The SEED and the rapid annotation of microbial genomes
using subsystems technology (RAST). Nucleic Acids Res. 42, D206–D214.
doi: 10.1093/nar/gkt1226
Frontiers in Microbiology | www.frontiersin.org 8 July 2017 | Volume 8 | Article 1322
fmicb-08-01322 July 11, 2017 Time: 15:44 # 9
Hindermann et al. S. serovar Infantis, Switzerland 2010–2015
Tate, H., Folster, J. P., Hsu, C. H., Chen, J., Hoffmann, M., Li, C., et al.
(2017). Comparative analysis of extended spectrum beta-lactamase CTX-M-
65-producing Salmonella infantis isolates from humans, food animals, and
retail chickens in the United States. Antimicrob. Agents Chemother. 61:e488-17.
doi: 10.1128/AAC.00488-17
Wilk, T., Szabó, M., Szmolka, A., Kiss, J., Barta, E., Nagy, T., et al. (2016). Genome
sequences of multidrug-resistant Salmonella enterica subsp. enterica serovar
Infantis strains from broiler chicks in Hungary. Genome Announc. 4:e1400-16.
doi: 10.1128/genomeA.01400-16
Wilk, T., Szabó, M., Szmolka, A., Kiss, J., Olasz, F., and Nagy, B. (2017). Genome
sequences of Salmonella enterica subsp. enterica serovar Infantis strains from
Hungary representing two peak incidence periods in three decades. Genome
Announc. 5:e1735-16. doi: 10.1128/genomeA.01735-16
Woodford, N., Fagan, E. J., and Ellington, M. J. (2006). Multiplex PCR for
rapid detection of genes encoding CTX-M extended-spectrum β-lactamases.
J. Antimicrob. Chemother. 57, 154–155.
Zurfluh, K., Nüesch-Inderbinen, M., Morach, M., Berner, A. Z., Hächler, H.,
and Stephan, R. (2015). Extended-spectrum ß-lactamase-producing-
Enterobacteriaceae in vegetables imported from the Dominican Republic,
India, Thailand and Vietnam. Appl. Environ. Microbiol. 81, 3115–3120.
doi: 10.1128/AEM.00258-15
Zurfluh, K., Wang, J., Klumpp, J., Nüesch-Inderbinen, M., Fanning, S., and
Stephan, R. (2014). Vertical transmission of highly similar blaCTX-M-1-
harboring IncI1 plasmids in Escherichia coli with different MLST types in the
poultry production pyramid. Front. Microbiol. 5:519. doi: 10.3389/fmicb.2014.
00519
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2017 Hindermann, Gopinath, Chase, Negrete, Althaus, Zurfluh, Tall,
Stephan and Nüesch-Inderbinen. This is an open-access article distributed under the
terms of the Creative Commons Attribution License (CC BY). The use, distribution or
reproduction in other forums is permitted, provided the original author(s) or licensor
are credited and that the original publication in this journal is cited, in accordance
with accepted academic practice. No use, distribution or reproduction is permitted
which does not comply with these terms.
Frontiers in Microbiology | www.frontiersin.org 9 July 2017 | Volume 8 | Article 1322
